🇺🇸 FDA

Drug profile · INN

parathyroid hormone

NATPAR

approved H05AA03
US status
approved
Patents linked
4
News articles
0

Quick answer

parathyroid hormone (NATPAR) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN parathyroid hormone
Brand NATPAR
Route INJECTION
Formulation INJECTABLE
ATC code H05AA03
Originator Takeda Pharmaceuticals International AG

Related patents

Search patents →

  1. US 12291556

    Parathyroid hormone variants

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7300919

    Pulmonary delivery of active fragments of parathyroid hormone

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7122624

    Parathyroid hormone receptor ligands

    Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 6025467

    Parathyroid hormone derivatives and their use

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is parathyroid hormone?

parathyroid hormone (NATPAR) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for parathyroid hormone?

NATPAR is a marketed brand name for parathyroid hormone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of parathyroid hormone?

parathyroid hormone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.